What is Phosphorus?
Phosphorus is dedicated to enhancing and extending lives by establishing genomics as a fundamental component of personal health. The company has developed a fully integrated genetic testing platform, encompassing wet lab chemistry, software, and bioinformatics. This verticalized approach enables Phosphorus to offer comprehensive, medical-grade genetic tests at accessible price points, thereby democratizing access to genomic information. Furthermore, Phosphorus extends its expertise through white-labeling, providing genomics-as-a-service solutions to organizations aiming to deploy their own preventative genetic testing programs. This strategic offering empowers healthcare providers to normalize preventative genomics within medical practice.
How much funding has Phosphorus raised?
Phosphorus has raised a total of $10M across 1 funding round:
Series A
$10M
Series A (2016): $10M with participation from FirstMark Capital
Key Investors in Phosphorus
FirstMark Capital
FirstMark Capital is a venture capital firm known for investing in early-stage technology companies. Their focus often includes software and data-driven businesses, aligning with Phosphorus's technology platform.
What's next for Phosphorus?
The substantial enterprise-level funding indicates Phosphorus is poised for significant scaling and market expansion. This capital injection will likely fuel advancements in their genetic testing technology, broaden their service offerings, and strengthen their partnerships within the healthcare ecosystem. The company's focus on democratizing genomic information suggests a strategic push towards wider adoption and integration into preventative healthcare strategies, potentially solidifying their position as a leader in the genomics-as-a-service sector.
See full Phosphorus company page
